Founder Paul DiPerna helped build one of the best-known insulin pumps at Tandem Diabetes (TNDM). His next bet is that a simpler device, backed by broader pharmacy access, can win over people who have never used one.
Modular Medical, Inc. (NASDAQ: MODD)…
Smart Glasses, Lunar Logistics and Simpler Diabetes Care Offer a Compelling Growth Theme
Wall Street’s most interesting growth stories do not always share an industry. Sometimes they share a commercial breakthrough: making something difficult easier to buy, use or deliver. Warby Parker…
New Patient Research Strengthens the Case for MODD's Pivot
Medical technology often competes by adding features. Modular Medical (NASDAQ:MODD) is pursuing a different proposition: make insulin delivery less demanding for the people who must manage it every day. New patient research announced…
Healthcare’s most compelling growth stories often begin with an unglamorous proposition: make an existing problem less difficult to manage. For INOVIO Pharmaceuticals (NASDAQ: INO), that means a newly approved immunotherapy intended to reduce repeated surgeries. For IDEXX Laboratories (NASDAQ: IDXX), it means…
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) has delivered the kind of Phase 3 result biotechnology investors wait patiently—and, on occasion, not so patiently—for. The company reported that avexitide reduced the composite rate of severe and clinically meaningful post-bariatric hypoglycemia events by 55% versus…
U.S. stocks rebounded Monday, June 8, 2026, led by a sharp recovery in semiconductor and other AI‑linked names after last week’s tech rout, even as investors digested hotter labor data, higher yields, and renewed Middle East tensions.
Market wrap: risk back on,…
MiniMed’s (MMED) IPO, Modular Medical’s (MODD) financing sprint, and Insulet’s (PODD) new data readout together sketch a surprisingly upbeat picture for diabetes tech investors watching the next leg of insulin-delivery innovation.
Diabetes Tech Steps Into the Spotlight
In early March, MiniMed Group,…
